Randall White

Program: Schizophrenia

 

Contact info

Detwiller Pavilion
2255 Wesbrook Mall
Vancouver, V6T2A1
6048271077

Professional Affiliations and other Positions

Fellow, Royal College of Physicians of Canada
Diplomate, American Board of Psychiatry and Neurology
Fellow, American Psychiatric Association
Fellow, Canadian Psychiatric Association
 

Biography

Dr. Randall F. White is medical director of the British Columbia Psychosis Program at UBC Hospital and has practiced psychiatry in Canada and the United States. His clinical and research interest is in managing treatment-resistant psychotic disorders, and he is also involved in various educational activities at UBC. He is co-chair of an annual psychopharmacology conference, supervises undergraduate and resident learners, lectures in the undergraduate medical program and to family medicine and psychiatry residents, and has produced CME for UBC CPD and Medscape.com. He has received several teaching awards and the Translation Research into Clinical Excellence in Psychiatry Settings (TRICEPS) Award from the UBC Department of Psychiatry in 2017

 

Selected Publications

Publications

White RF, Honer WG, Procyshyn R, Vila-Rodriguez F. Dimenhydrinate use disorder with chronic psychosis: a case report and focused literature review. Journal of Clinical Psychopharmacology. 2015;35(1):105-107.

Wang CK, Xu MS, Ross CJ, Lo  R, Vila-Rodriguez F, White RF, Honer WG, Barr AM. Development of a cost-efficient novel method for rapid, concurrent genotyping of five common single nucleotide polymorphisms of the brain derived neurotrophic factor (BDNF) gene by tetra-primer amplification refractory mutation system. Int J Methods Psychiatr Res. 2015;24(3):235-244.

Lee H, White RF, Barr AM, Honer WG, Procyshyn RM. Elevated clozapine plasma concentration secondary to a urinary tract infection: proposed mechanisms. J Psychiatry Neurosci. 2016;41(4): 67-68.

Kim DD, Lang DD, Warburton D, Barr AM, Smith GN, Thornton AE, White RF, Honer WG, Procyshyn RM. Effects of exercise on serum triglycerides and symptoms of schizophrenia. Journal of Clinical Psychopharmacology. 2017;37(2).

Kim D, Lang DJ, Barr  AM, White RF, Honer WG, Procyshyn RM. Exercise-associated extrapyramidal symptoms during treatment with long-acting injectable antipsychotics. Journal of Clinical Psychopharmacology. Clinical Schizophrenia and Related Psychoses. Published online, Aug 4, 2017.

Abstracts

Fredrikson D, White RF, Chan AW, Lagnado G, Feeney S, Corral M.  The Metabolic Monitoring Care Pathway at St. Paul’s Hospital: An Integrated Continuum of Care. Poster presentation, World Congress of Social Psychiatry, Marrakech, Morocco, October 23-27, 2010. (poster)

Stowe R, Tyson C, Hrynchak M, White RF, Lang D, Bailey A, Macleod P, Honer W.  A 21year-old man with autism spectrum disorder, refractory schizophrenia, facial dysmorphism and a duplication of chromosome 7q36 that overlaps with  DPP6. American Neuropsychiatric Association Annual Meeting, February 15-18, 2014 Seattle, USA. 

Lang DJ, Warburton DE, Humphries B, Su W, O Leonova, White R, Thornton AE, and Honer WG. Differential effects of clozapine exposure compared to standard second-generation antipsychotics on hippocampal volumes in chronic schizophrenia. International College of Neuropsychopharmacology World Congress, June 22-26, 2014, Vancouver, BC. (poster)

White RF, Smith GN, Flynn SW, Torres I, Honer WG. Treatment-resistant psychosis: diagnostic and clinical characteristics of a large case series. American Psychiatric Association Institute on Psychiatric Services, October 31- November 2, 2014, San Francisco, USA. (poster)

White RF, Honer WG, Procyshyn R, Vila-Rodriguez F. Dimenhydrinate use disorder with chronic psychosis: a case report and focused literature review. Pacific Rim College of Psychiatrists, October 2014, Vancouver, BC. (poster)

K Gicas, AE Thornton, T O’Connor,DE Warburton, WG Honer, GN Smith, VM Goghari, RF White, O Leonova, A Rauscher, AA Phillips, B Humphries, F Vila-Rodriguez, AT Vertinsky and DJ Lang. Improvements in aerobic fitness and brain health are associated with better memory in chronic schizophrenia patients. International Congress on Schizophrenia Research. March 2015, Colorado Springs, USA. (poster)

DJ Lang, A Rauscher, AE Thornton, K Gicas, GN Smith, VM Goghari, O Leonova, RF White, F Vila-Rodriguez, W Su, B Humphries, AA Philips, WG Honer, DE Warburton, AT Vertinsky. Exercise-associated hippocampal plasticity and hippocampal microvascular plasticity in chronic refractory schizophrenia patients. International Congress on Schizophrenia Research. March 2015, Colorado Springs, USA. (poster)

White RF, Smith GN, Flynn SW, Procyshyn R, Fidel-Rodriguez F, Honer WG. Characteristics, pharmacotherapy, and treatment outcomes of a large cohort of patients with treatment-resistant psychosis. International Congress on Schizophrenia Research. March 2015, Colorado Springs, USA. (poster)

Woodward ML, Su W, White RF, Leonova O, Philips AA, Warburton DE, Rauscher A, Lang DJ. Effects of exercise on basal ganglia morphology in schizophrenia. 9th Annual Canadian Neuroscience Meeting, May 2015, Vancouver, BC. (poster)

White RF, Smith GN, Honer  WG. Diagnostic profile of a cohort of patients with treatment-resistant psychosis. Canadian Psychiatric Association Annual Conference, October 1, 2015, Vancouver, BC.

Ainsworth NJ, Leon A, Green K, White RF, Sung J, Shalbaf R, Aur D, SIngh A, Smith GN, Honer WG, Vila-Rodriguez, F. Clinical response to electroconvulsive therapy among patients with treatment-refractory psychosis: The BC Psychosis Program experience. Second Annual International Brain Stimulation Conference, March 5-8, 2017; Barcelona, Spain. (poster)

White RF, Smith GN,  Li J, Neelakant H, Ponnachana S, Procyshyn R, Barr A, Honer WG. A proposed algorithm for managing clozapine-resistant psychosis. American Psychiatric Association Annual Meeting, May 20-24, 2017; San Diego, California, USA. (poster)

 

 

Program members: